HaDEA opens 2025 EU4Health proposals focused on CBRN threats and vector-borne diseases and crisis preparedness
The European Health and Digital Executive Agency (HaDEA) has announced new funding opportunities under the 2025 EU4Health Work Programme. This new funding will improve the European Union’s crisis preparedness and response to future health emergencies.
These calls for proposals are focused on the development of innovative medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, as well as advanced diagnostics for vector-borne diseases.
Applications are open until 4 December 2025 at 17:00 CEST, through the EU Funding and Tenders Portal.
Focusing on CBRN medical countermeasures
The first central funding line, EU4H-2025-HERA-PJ-1, invites proposals to support the development of cutting-edge medical tools to counter CBRN threats. This call, along with the Health Emergency Preparedness and Response Authority (HERA), is divided into three subtopics:
- Medicinal Products (EU4H-2025-HERA-PJ-1-a):
- Funding will support the development of innovative medicinal products to prevent or treat illnesses resulting from CBRN exposure.
- Reusable Respiratory PPE and Protection Suits (EU4H-2025-HERA-PJ-1-b):
- This subtopic targets innovation in high-quality, reusable personal protective equipment designed for use in CBRN environments.
- Detection and Diagnosis (EU4H-2025-HERA-PJ-1-c):
- This part of the call supports the development of technologies for rapid detection and accurate diagnosis of CBRN-related threats.
These initiatives aim to enhance the EU’s crisis preparedness for health emergencies, enhance civilian protection, and ensure the availability of effective countermeasures during crises.
Diagnostics for vector-borne diseases
The second major funding call, EU4H-2025-HERA-PJ-2, addresses the growing concern of vector-borne diseases (VBDs), which are transmitted by insects such as mosquitoes and ticks. The call focuses on the development of innovative diagnostic tests that can help health systems detect and manage these diseases more effectively.
With climate change and increased global travel contributing to the spread of VBDs like dengue, chikungunya, and Lyme disease, the EU aims to strengthen health surveillance and early detection capabilities. Improved diagnostics are expected to play a key role in reducing the burden of these diseases and enhancing public health resilience.
Information session on 15 September
To support potential applicants, HaDEA and HERA will host an Info Session on Monday, 15 September 2025, from 14:30 to 17:00 CEST. The session will provide an overview of the calls, including their policy background, objectives, expected outcomes, and application procedures. Interested participants are encouraged to register in advance to secure their attendance.
These calls form part of the EU4Health programme, the EU’s largest health funding initiative to date. Launched in response to the COVID-19 pandemic, EU4Health aims to build more resilient healthcare systems across Europe. By supporting innovation in medical technologies, public health infrastructure, and cross-border cooperation, the programme contributes to a healthier and more secure Europe.
From 2021 to 2027, HaDEA is responsible for implementing most of the EU4Health budget, managing grants and tenders to support a wide range of health-related projects.
![Figure 1 - The figure illustrates the diversity and multi-scale nature of the structures in the Galaxy. The first two lines are real astronomical images, which go from the galactic disk itself and down to the planet-forming disks. The last two lines are generated from numerical simulations and aim to understand and interpret the observations. [adapted from Facchini et al. 2025, Göller et al. 2025, Hennebelle et al. 2022, Lebreuilly et al. 2024, Molinari et al. 2016, 2025, Reissl et al. 2016]](https://www.openaccessgovernment.org/wp-content/uploads/2025/08/figure-100x70.png "Predictive modelling of galactic star and planet formation")
